JP6003000B2 - Cosmetics and method for producing cosmetics - Google Patents
Cosmetics and method for producing cosmetics Download PDFInfo
- Publication number
- JP6003000B2 JP6003000B2 JP2013034363A JP2013034363A JP6003000B2 JP 6003000 B2 JP6003000 B2 JP 6003000B2 JP 2013034363 A JP2013034363 A JP 2013034363A JP 2013034363 A JP2013034363 A JP 2013034363A JP 6003000 B2 JP6003000 B2 JP 6003000B2
- Authority
- JP
- Japan
- Prior art keywords
- cosmetic
- acid salt
- cosmetic according
- oil
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 99
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 239000002253 acid Substances 0.000 claims description 115
- 150000003839 salts Chemical class 0.000 claims description 58
- 229920000642 polymer Polymers 0.000 claims description 45
- 238000006068 polycondensation reaction Methods 0.000 claims description 40
- 239000012071 phase Substances 0.000 claims description 38
- 239000002245 particle Substances 0.000 claims description 36
- 125000001165 hydrophobic group Chemical group 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 23
- 239000000839 emulsion Substances 0.000 claims description 20
- 150000003384 small molecules Chemical class 0.000 claims description 19
- 230000002209 hydrophobic effect Effects 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 125000005313 fatty acid group Chemical group 0.000 claims description 15
- 235000012000 cholesterol Nutrition 0.000 claims description 14
- 239000006185 dispersion Substances 0.000 claims description 12
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000004094 surface-active agent Substances 0.000 claims description 10
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims description 8
- 210000002472 endoplasmic reticulum Anatomy 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 7
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 7
- 229940106189 ceramide Drugs 0.000 claims description 7
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 7
- 238000002844 melting Methods 0.000 claims description 7
- 230000008018 melting Effects 0.000 claims description 7
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000008346 aqueous phase Substances 0.000 claims description 6
- 229960000735 docosanol Drugs 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 5
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 5
- 229940032094 squalane Drugs 0.000 claims description 5
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 150000002431 hydrogen Chemical group 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- OOWQBDFWEXAXPB-IBGZPJMESA-N 1-O-hexadecyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](O)CO OOWQBDFWEXAXPB-IBGZPJMESA-N 0.000 claims description 2
- JAUFWPNLLLUYNV-UHFFFAOYSA-N 3-(16-methylheptadecoxy)propane-1,2-diol Chemical compound CC(C)CCCCCCCCCCCCCCCOCC(O)CO JAUFWPNLLLUYNV-UHFFFAOYSA-N 0.000 claims description 2
- OOWQBDFWEXAXPB-UHFFFAOYSA-N chimyl alcohol Natural products CCCCCCCCCCCCCCCCOCC(O)CO OOWQBDFWEXAXPB-UHFFFAOYSA-N 0.000 claims description 2
- NRWMBHYHFFGEEC-MDZDMXLPSA-N 3-[(e)-octadec-9-enoxy]propane-1,2-diol Chemical compound CCCCCCCC\C=C\CCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-MDZDMXLPSA-N 0.000 claims 1
- NRWMBHYHFFGEEC-UHFFFAOYSA-N selachyl alcohol Natural products CCCCCCCCC=CCCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-UHFFFAOYSA-N 0.000 claims 1
- 239000003921 oil Substances 0.000 description 53
- 235000019198 oils Nutrition 0.000 description 53
- 239000000194 fatty acid Substances 0.000 description 17
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 11
- 238000004945 emulsification Methods 0.000 description 11
- -1 hydroxypropyl group Chemical group 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 6
- 239000004166 Lanolin Substances 0.000 description 4
- 150000001298 alcohols Chemical group 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 150000001783 ceramides Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 108700004121 sarkosyl Proteins 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- AFSHUZFNMVJNKX-LLWMBOQKSA-N 1,2-dioleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC\C=C/CCCCCCCC AFSHUZFNMVJNKX-LLWMBOQKSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- VRBHTEGUHVNKEA-UHFFFAOYSA-N 16-methylheptadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C VRBHTEGUHVNKEA-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- SGPMPZKXUXPIBJ-UHFFFAOYSA-N C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC Chemical compound C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC SGPMPZKXUXPIBJ-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- JUYVAAUKKZVJME-UHFFFAOYSA-N OCC(CO)(COCC(CO)(CO)CO)CO.OC(C(=O)O)CCCCCCCCCCCCCCCC.OC(C(=O)O)CCCCCCCCCCCCCCCC.OC(C(=O)O)CCCCCCCCCCCCCCCC.OC(C(=O)O)CCCCCCCCCCCCCCCC.OC(C(=O)O)CCCCCCCCCCCCCCCC.OC(C(=O)O)CCCCCCCCCCCCCCCC Chemical compound OCC(CO)(COCC(CO)(CO)CO)CO.OC(C(=O)O)CCCCCCCCCCCCCCCC.OC(C(=O)O)CCCCCCCCCCCCCCCC.OC(C(=O)O)CCCCCCCCCCCCCCCC.OC(C(=O)O)CCCCCCCCCCCCCCCC.OC(C(=O)O)CCCCCCCCCCCCCCCC.OC(C(=O)O)CCCCCCCCCCCCCCCC JUYVAAUKKZVJME-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 240000002871 Tectona grandis Species 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- GORMSINSWZJIKL-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-dimethylpropyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(C)(C)COC(=O)C(CC)CCCC GORMSINSWZJIKL-UHFFFAOYSA-N 0.000 description 1
- CFRNDJFRRKMHTL-UHFFFAOYSA-N [3-octanoyloxy-2,2-bis(octanoyloxymethyl)propyl] octanoate Chemical compound CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC CFRNDJFRRKMHTL-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 125000004395 glucoside group Chemical group 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N glyceric acid Chemical compound OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000012835 hanging drop method Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000008384 inner phase Substances 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229940041290 mannose Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940074096 monoolein Drugs 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Description
本発明は、化粧料及び化粧料の製造方法に関する。 The present invention relates to a cosmetic and a method for producing the cosmetic.
化粧料は多機能を求められることから、多様な機能性油性基剤や機能性顆粒を一つの化粧料の中に安定に維持することが要求され、これを満たすことは非常に難しい。化粧料に最適な乳化剤を選択するためには、非常に煩雑かつ多大な労力を必要としながら、多種類の機能性油性基剤が混在している化粧料では安定な乳化を得ることが困難な場合が多い。 Since cosmetics are required to have multiple functions, it is required to stably maintain various functional oily bases and functional granules in one cosmetic, which is very difficult to satisfy. In order to select the most suitable emulsifier for cosmetics, it is very cumbersome and requires a lot of labor, but it is difficult to obtain a stable emulsification with cosmetics containing various types of functional oil bases. There are many cases.
本発明者らは、その改善策として、特定の多糖類等を乳化分散剤として用いることで、界面活性剤に依存せずに高い乳化分散安定性を有する化粧料を発明し、開示している(特許文献1参照)。 The inventors have invented and disclosed a cosmetic having high emulsification dispersion stability without depending on a surfactant by using a specific polysaccharide or the like as an emulsification dispersant as an improvement measure. (See Patent Document 1).
しかし、特許文献1に示される化粧料は、外観(油膜、油滴が過多)及び使用感(べたつき感が過多)の点で十分ではなく、向上の余地が残されている。 However, the cosmetic shown in Patent Document 1 is not sufficient in terms of appearance (excessive oil film and oil droplets) and feeling of use (excessive stickiness), and there is room for improvement.
本発明は、以上の実情に鑑みてなされたものであり、外観(油膜、油滴を減らす)及び使用感(べたつき感を減らす)を向上できかつ乳化性能に優れる化粧料及びその製造方法を提供することを目的とする。 The present invention has been made in view of the above circumstances, and provides a cosmetic that can improve the appearance (reducing oil film and oil droplets) and the feeling of use (reducing the stickiness) and has excellent emulsification performance, and a method for producing the same. The purpose is to do.
本発明者らは、水酸基の一部に疎水性基が導入された重縮合ポリマー粒子、又はα,ω−ジ脂肪酸トリアミノ酸塩及び前記α,ω−ジ脂肪酸トリアミノ酸塩が有する脂肪酸基同士の間にとりこまれる疎水性の低分子化合物を有する閉鎖小胞体を用いることで、外観及び使用感(べたつき感)が向上することを見出し、本発明を完成するに至った。具体的に、本発明は以下のものを提供する。 The inventors of the present invention provide a polycondensation polymer particle in which a hydrophobic group is introduced into a part of a hydroxyl group, or an α, ω-difatty acid triamino acid salt and the fatty acid groups of the α, ω-difatty acid triamino acid salt. It has been found that the appearance and feeling of use (stickiness) are improved by using a closed endoplasmic reticulum having a hydrophobic low-molecular compound intercalated in between, and the present invention has been completed. Specifically, the present invention provides the following.
(1) (A)水相、
(B)油相、並びに
(C−1)水酸基を有しかつ一部に疎水性基が導入された重縮合ポリマー粒子、及び/又は(C−2)α,ω−ジ脂肪酸トリアミノ酸塩及び前記α,ω−ジ脂肪酸トリアミノ酸塩が有する脂肪酸基同士の間にとりこまれる疎水性の低分子化合物を有する閉鎖小胞体
を含む化粧料。
(1) (A) Aqueous phase,
(B) an oil phase, and (C-1) a polycondensation polymer particle having a hydroxyl group and having a hydrophobic group partially introduced therein, and / or (C-2) an α, ω-difatty acid triamino acid salt and A cosmetic comprising a closed endoplasmic reticulum having a hydrophobic low-molecular compound incorporated between the fatty acid groups of the α, ω-difatty acid triamino acid salt.
(2) 前記疎水性基は、置換又は非置換の長鎖アルキル基を含む(1)記載の化粧料。 (2) The cosmetic according to (1), wherein the hydrophobic group includes a substituted or unsubstituted long-chain alkyl group.
(3) 前記長鎖アルキル基は、炭素数8以上22以下のアルキル基である(2)記載の化粧料。 (3) The cosmetic according to (2), wherein the long-chain alkyl group is an alkyl group having 8 to 22 carbon atoms.
(4) 前記重縮合ポリマーは、糖ポリマーを含む(1)から(3)いずれか記載の化粧料。 (4) The cosmetic according to any one of (1) to (3), wherein the polycondensation polymer includes a sugar polymer.
(5) 前記水酸基の一部に疎水性基が導入された重縮合ポリマーは、一般式1で示される化合物を含む(4)記載の化粧料。
式中、Rは、各々独立して、水素、メチル、−[R’O]mH(式中、R’はアルキル基、mは1以上の整数である)、又は−R’’OCpH2p+1(式中、R’’は側鎖に水酸基を有するアルキル基、pは8以上22以下の整数である)であり、nは100以上の整数である。
(5) The cosmetic according to (4), wherein the polycondensation polymer in which a hydrophobic group is introduced into a part of the hydroxyl group includes a compound represented by the general formula 1.
In the formula, each R is independently hydrogen, methyl, — [R′O] m H (where R ′ is an alkyl group, m is an integer of 1 or more), or —R ″ OC p. H 2p + 1 (wherein R ″ is an alkyl group having a hydroxyl group in the side chain, p is an integer of 8 to 22, and n is an integer of 100 or more).
(6) 前記α,ω−ジ脂肪酸トリアミノ酸塩は、一般式2で示される化合物を含む(1)から(5)いずれか記載の化粧料。
式中、a及びbは、独立して、9以上15以下の炭素数を有し、XはNa又は水素である。
(6) The cosmetic according to any one of (1) to (5), wherein the α, ω-difatty acid triamino acid salt includes a compound represented by Formula 2.
In the formula, a and b independently have 9 to 15 carbon atoms, and X is Na or hydrogen.
(7) 前記低分子化合物は、コレステロール、セラミド、及びそれらの誘導体からなる群より選ばれる1種以上を含む(1)から(6)いずれか記載の化粧料。 (7) The cosmetic according to any one of (1) to (6), wherein the low molecular compound includes one or more selected from the group consisting of cholesterol, ceramide, and derivatives thereof.
(8) 高級アルコールを更に含有する(1)から(7)いずれか記載の化粧料。 (8) The cosmetic according to any one of (1) to (7), further containing a higher alcohol.
(9) 前記高級アルコールは、ステアリルアルコール及びベヘニルアルコールを含む(8)記載の化粧料。 (9) The cosmetic according to (8), wherein the higher alcohol includes stearyl alcohol and behenyl alcohol.
(10) モノ脂肪酸グリセリンエーテル(ただし、脂肪酸の炭素数は16以上である)を更に含有する(1)から(9)いずれか記載の化粧料。 (10) The cosmetic according to any one of (1) to (9), further containing a mono fatty acid glycerin ether (wherein the fatty acid has 16 or more carbon atoms).
(11) 前記重縮合ポリマー粒子及び/又は前記閉鎖小胞体は、前記水相及び前記油相の界面に介在し、乳化状態を構成する(1)から(10)いずれか記載の化粧料。 (11) The cosmetic according to any one of (1) to (10), wherein the polycondensation polymer particles and / or the closed vesicles are interposed in an interface between the water phase and the oil phase to constitute an emulsified state.
(12) 界面活性剤を実質的に含有しない(1)から(11)いずれか記載の化粧料。 (12) The cosmetic according to any one of (1) to (11), which contains substantially no surfactant.
(13) 界面活性剤を更に含有する(1)から(11)いずれか記載の化粧料。 (13) The cosmetic according to any one of (1) to (11), further containing a surfactant.
(14) 前記油相は、水に対して25mN/m以上の平均界面張力を有する油からなる(1)から(13)いずれか記載の化粧料。 (14) The cosmetic according to any one of (1) to (13), wherein the oil phase is made of an oil having an average interfacial tension of 25 mN / m or more with respect to water.
(15) 前記油相は、スクワランを含む(1)から(14)いずれか記載の化粧料。 (15) The cosmetic according to any one of (1) to (14), wherein the oil phase includes squalane.
(16) 水酸基を有しかつ一部に疎水性基が導入された重縮合ポリマー粒子、並びに/又はα,ω−ジ脂肪酸トリアミノ酸塩及び前記α,ω−ジ脂肪酸トリアミノ酸塩が有する脂肪酸基同士の間にとりこまれた疎水性の低分子化合物を有する閉鎖小胞体が分散した水分散液と、油成分と、を混合し、水相及び油相を互いに乳化させる工程を有する化粧料の製造方法。 (16) Polycondensation polymer particles having a hydroxyl group and partially introduced with a hydrophobic group, and / or a fatty acid group possessed by an α, ω-difatty acid triamino acid salt and the α, ω-difatty acid triamino acid salt Manufacture of cosmetics having a step of mixing an aqueous dispersion in which closed vesicles having hydrophobic low-molecular compounds incorporated between them are dispersed and an oil component, and emulsifying the aqueous phase and the oil phase with each other Method.
(17) α,ω−ジ脂肪酸トリアミノ酸塩及び疎水性の低分子化合物をpH3.5〜4.5の条件下で水に分散させた後、pHを6.0〜7.0に戻し、前記水分散液に添加することで、前記閉鎖小胞体を調製する工程を更に有する(16)記載の方法。 (17) After the α, ω-difatty acid triamino acid salt and the hydrophobic low molecular weight compound are dispersed in water under the conditions of pH 3.5 to 4.5, the pH is returned to 6.0 to 7.0, The method according to (16), further comprising a step of preparing the closed vesicle by adding to the aqueous dispersion.
(18) 高級アルコールを前記水分散液に添加し、前記高級アルコールの融点以上の温度において溶解させ、前記融点以下の温度へと冷却した後、前記油成分を混合する(16)又は(17)記載の方法。 (18) A higher alcohol is added to the aqueous dispersion, dissolved at a temperature equal to or higher than the melting point of the higher alcohol, cooled to a temperature equal to or lower than the melting point, and then mixed with the oil component (16) or (17) The method described.
本発明によれば、水酸基を有しかつ一部に疎水性基が導入された重縮合ポリマー粒子を含むことで、外観(油膜、油滴)及び使用感(べたつき感)を向上できかつ乳化性能に優れる化粧料を提供することができる。 According to the present invention, by including polycondensation polymer particles having a hydroxyl group and having a hydrophobic group partially introduced, the appearance (oil film, oil droplets) and the feeling of use (stickiness) can be improved and the emulsification performance It is possible to provide cosmetics that are excellent in quality.
以下、本発明の実施形態を説明するが、これらに本発明が限定されるものではない。 Hereinafter, although embodiment of this invention is described, this invention is not limited to these.
本発明に係る化粧料は、(A)水相、(B)油相、並びに(C−1)水酸基を有しかつ一部に疎水性基が導入された重縮合ポリマー粒子、及び/又は(C−2)α,ω−ジ脂肪酸トリアミノ酸塩及び前記α,ω−ジ脂肪酸トリアミノ酸塩が有する脂肪酸基同士の間にとりこまれる疎水性の低分子化合物を有する閉鎖小胞体を含む。重縮合ポリマー粒子及び閉鎖小胞体は、水相及び油相の界面に介在し、ファンデルワールス力を介して乳化状態を構成することから、油相及び水相の組成や条件にかかわらず、良好な乳化状態を構成することができる。この機構を利用して化粧料で用いられてきた乳化剤として多糖類ポリマーが挙げられるが、これらの多糖類ポリマーに比べ、水酸基を有しかつ一部に疎水性基が導入された重縮合ポリマー粒子、及びα,ω−ジ脂肪酸トリアミノ酸塩が有する脂肪酸基同士の間にとりこまれる疎水性の低分子化合物を有する閉鎖小胞体は、外観(油膜、油滴を減らす)及び使用感(べたつき感を減らす)を向上できる点で優位である。 The cosmetic according to the present invention comprises (A) an aqueous phase, (B) an oil phase, (C-1) a polycondensation polymer particle having a hydroxyl group and having a hydrophobic group partially introduced therein, and / or ( C-2) A closed endoplasmic reticulum having an α, ω-difatty acid triamino acid salt and a hydrophobic low-molecular compound incorporated between the fatty acid groups of the α, ω-difatty acid triamino acid salt. Polycondensation polymer particles and closed vesicles intervene at the interface between the water phase and the oil phase, and constitute an emulsified state via van der Waals forces, so they are good regardless of the composition and conditions of the oil phase and the water phase. A simple emulsified state. Emulsifiers that have been used in cosmetics using this mechanism include polysaccharide polymers. Compared to these polysaccharide polymers, polycondensation polymer particles that have hydroxyl groups and partially introduced hydrophobic groups , And α, ω-difatty acid triamino acid salts have hydrophobic low molecular weight compounds that are trapped between the fatty acid groups, and the appearance (oil film, reduce oil droplets) and feeling of use (stickiness) It is advantageous in that it can be improved.
外観(油膜、油滴を減らす)及び使用感(べたつき感を減らす)が向上する機構は、親水性部分である水酸基が外側に、疎水性部分である疎水性基が内側に向くことで、重縮合ポリマー粒子が強固な構造体になるため、油相の水に対する界面張力が大きくても、粒子構造を保持し、乳化能力を損ないにくいことによると推測される。また、閉鎖小胞体の場合も類似しており、脂肪酸基同士の間に疎水性の低分子化合物がとりこまれることで、脂肪酸基の立体配置が安定化し、α,ω−ジ脂肪酸トリアミノ酸塩の効果が安定的に奏されることによると推測される。 The mechanism that improves the appearance (reduces oil film and oil droplets) and the feeling of use (reduces stickiness) is that the hydroxyl group, which is a hydrophilic part, faces outward, and the hydrophobic group, which is a hydrophobic part, faces inward. Since the condensation polymer particles have a strong structure, it is presumed that even if the interfacial tension of the oil phase with respect to water is large, the particle structure is maintained and the emulsification ability is hardly impaired. Moreover, the case of the closed endoplasmic reticulum is similar, and the configuration of the fatty acid group is stabilized by incorporating a hydrophobic low molecular weight compound between the fatty acid groups, and α, ω-difatty acid triamino acid salt It is presumed that this effect is stably achieved.
「疎水性基が導入された」は、疎水性基を有しない重縮合ポリマーに疎水性基を事後的に導入してなるものに限られず、元来疎水性基を有する重縮合ポリマーも包含するが、水酸基と疎水性基とによるエステル結合を有することは必須である。 “Hydrophobic group introduced” is not limited to a polymer obtained by subsequent introduction of a hydrophobic group into a polycondensation polymer having no hydrophobic group, but also includes a polycondensation polymer originally having a hydrophobic group. However, it is essential to have an ester bond with a hydroxyl group and a hydrophobic group.
疎水性基は、疎水結合により重縮合ポリマー粒子の構造を強固にするものであり、このような機能を有する疎水性基自体は従来周知であり、強固にすべき程度に応じ適宜選択されてよい。中でも、疎水性基は、外観及び使用感の向上効果に優れる点で、置換又は非置換の長鎖アルキル基を含むことが好ましい。長鎖アルキル基は、直鎖又は分岐鎖のいずれでもよく、炭素数が過小であると、粒子の構造強化の効果が不十分であるおそれがあるため、炭素数が8以上、10以上、12以上、14以上、16以上、18以上であってよく、炭素数が8以上22以下であることが好ましく、例えばステアリル基が挙げられる。なお、重縮合ポリマーに導入される疎水性基は、1種でもよく、2種以上であってもよい。 Hydrophobic groups are those that strengthen the structure of polycondensation polymer particles by hydrophobic bonds, and hydrophobic groups having such functions themselves are well known in the art and may be appropriately selected depending on the degree to be strengthened. . Especially, it is preferable that a hydrophobic group contains a substituted or unsubstituted long chain alkyl group at the point which is excellent in the improvement effect of an external appearance and a usability | use_condition. The long chain alkyl group may be either a straight chain or a branched chain, and if the carbon number is too small, the effect of strengthening the structure of the particles may be insufficient, so the carbon number is 8 or more, 10 or more, 12 As described above, it may be 14 or more, 16 or more, or 18 or more, and preferably has 8 to 22 carbon atoms, and examples thereof include a stearyl group. In addition, the hydrophobic group introduce | transduced into a polycondensation polymer may be 1 type, and 2 or more types may be sufficient as it.
疎水性基の導入量は、過小であると、重縮合ポリマー粒子の構造強固が不十分になりやすく、過大であると、水酸基が不足し、油相になじみすぎて乳化性能が不十分になりやすい。具体的な疎水性の導入量は、用いる疎水性基及び重縮合ポリマーによって適宜選択されてよく、例えば重縮合ポリマー中の水酸基(疎水化されていない水酸基)に対する疎水性基の導入率が、0.2〜2.0(具体的には、0.24〜1.63)質量%程度であってよい。 If the introduction amount of the hydrophobic group is too small, the structural strength of the polycondensation polymer particles tends to be insufficient, and if it is too large, the hydroxyl group is insufficient and the emulsification performance becomes insufficient due to being too familiar with the oil phase. Cheap. The specific amount of hydrophobic introduction may be appropriately selected depending on the hydrophobic group and the polycondensation polymer to be used. For example, the introduction ratio of the hydrophobic group to the hydroxyl group (non-hydrophobized hydroxyl group) in the polycondensation polymer is 0. .2 to 2.0 (specifically, 0.24 to 1.63) mass%.
水酸基を有する重縮合ポリマーは、天然高分子又は合成高分子のいずれであってもよく、乳化剤の用途に応じて適宜選択されてよい。ただし、安全性に優れ、一般的に安価である点で、天然高分子が好ましく、乳化機能に優れる点で以下に述べる糖ポリマーがより好ましい。 The polycondensation polymer having a hydroxyl group may be either a natural polymer or a synthetic polymer, and may be appropriately selected according to the use of the emulsifier. However, natural polymers are preferable from the viewpoint of safety and generally inexpensive, and sugar polymers described below are more preferable from the viewpoint of excellent emulsifying function.
糖ポリマーは、セルロース、デンプン等のグルコシド構造を有するポリマーである。例えば、リボース、キシロース、ラムノース、フコース、グルコース、マンノース、グルクロン酸、グルコン酸などの単糖類の中からいくつかの糖を構成要素として微生物が産生するもの、キサンタンガム、アラビアゴム、グアーガム、カラヤガム、カラギーナン、ペクチン、フコイダン、クインシードガム、トラントガム、ローカストビーンガム、ガラクトマンナン、カードラン、ジェランガム、フコゲル、カゼイン、ゼラチン、デンプン、コラーゲンなどの天然高分子、メチルセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、カルボキシメチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース、カルボキシメチルセルロースナトリウム、アルギン酸プロピレングリコールエステル、セルロース結晶体、デンプン・アクリル酸ナトリウムグラフト重合体、疎水化ヒドロキシプロピルメチルセルロースなどの半合成高分子、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、ポリアクリル酸塩、ポリエチレンオキシドなどの合成高分子が挙げられる。 The sugar polymer is a polymer having a glucoside structure such as cellulose and starch. For example, those produced by microorganisms with some sugars among monosaccharides such as ribose, xylose, rhamnose, fucose, glucose, mannose, glucuronic acid, gluconic acid, xanthan gum, gum arabic, guar gum, caraya gum, carrageenan , Pectin, fucoidan, quinseed gum, tranto gum, locust bean gum, galactomannan, curdlan, gellan gum, fucogel, casein, gelatin, starch, collagen and other natural polymers, methylcellulose, ethylcellulose, methylhydroxypropylcellulose, carboxymethylcellulose, Hydroxymethylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose, propylene glycol alginate, cell Examples include semi-synthetic polymers such as glucose crystals, starch / sodium acrylate graft polymers, hydrophobized hydroxypropylmethylcellulose, and synthetic polymers such as polyvinyl alcohol, polyvinyl pyrrolidone, carboxyvinyl polymer, polyacrylate, and polyethylene oxide. It is done.
水酸基の一部に疎水性基が導入された重縮合ポリマーは、一般式1で示される化合物を含んでよい。
式中、Rは、各々独立して、水素、メチル、−[R’O]mH(式中、R’はアルキル基、mは1以上の整数である)、又は−R’’OCpH2p+1(式中、R’’は側鎖に水酸基を有するアルキル基、pは8以上22以下の整数である)であり、nは100以上の整数である。nは、過小であると安定な粒子を形成しにくいが、本発明では疎水性基が導入されて安定な粒子が形成されやすいため、従来よりも低い値もとり得る。具体値は、適宜設定されてよく、例えば500以上、1000以上、1500以上、2000以上であってよい。R’及びR’’は、一般式1の化合物を合成する際に用いられる基にすぎず、種々のものであってよく、例えばR’は炭素数1〜3程度のアルキル基であってよく、R’’はヒドロキシプロピル基であってよい。
The polycondensation polymer in which a hydrophobic group is introduced into a part of the hydroxyl group may contain a compound represented by the general formula 1.
In the formula, each R is independently hydrogen, methyl, — [R′O] m H (where R ′ is an alkyl group, m is an integer of 1 or more), or —R ″ OC p. H 2p + 1 (wherein R ″ is an alkyl group having a hydroxyl group in the side chain, p is an integer of 8 to 22, and n is an integer of 100 or more). When n is too small, it is difficult to form stable particles. However, in the present invention, a hydrophobic group is introduced and stable particles are easily formed, and therefore can take a lower value than before. The specific value may be set as appropriate, and may be, for example, 500 or more, 1000 or more, 1500 or more, or 2000 or more. R ′ and R ″ are only groups used in synthesizing the compound of the general formula 1, and may be various groups. For example, R ′ may be an alkyl group having about 1 to 3 carbon atoms. , R ″ may be a hydroxypropyl group.
具体的には、例えば、疎水化ヒドロキシプロピルメチルセルロース(例えば、ステアロキシヒドロキシプロピルメチルセルロース)が挙げられ、大同化成社製「サンジェロース」(商標)「60L」、「90L」や、「60M」、「90M」等の市販品も使用できる。 Specifically, for example, hydrophobized hydroxypropyl methylcellulose (for example, stearoxyhydroxypropylmethylcellulose) can be mentioned, and “Sangelose” (trademark) “60L”, “90L”, “60M”, “60M”, “ Commercial products such as “90M” can also be used.
重縮合ポリマー粒子は、粒度分布測定装置FPAR(大塚電子(株)社製)で測定される平均粒径が8nm〜500nmの範囲であり、これにより均質かつ優れた乳化機能を有する。調製方法は、特許第3855203号等に開示されるとおり、従来公知であるため、省略する。 The polycondensation polymer particles have an average particle size in the range of 8 nm to 500 nm as measured by a particle size distribution measuring device FPAR (manufactured by Otsuka Electronics Co., Ltd.), thereby having a homogeneous and excellent emulsifying function. Since the preparation method is conventionally known as disclosed in Japanese Patent No. 3855203, etc., it will be omitted.
重縮合ポリマーの量は、過小であると、上記効果が不十分になりやすく、過大であると、化粧料の皮膚上での延びが悪くなる場合がある。重縮合ポリマーの量は、上記傾向に基づき化粧料の用途に応じて適宜設定されてよく、化粧料に対し0.01質量%以上であることが好ましく、より好ましくは0.05質量%以上である。また、重縮合ポリマーの量は、化粧料に対し2質量%以下であることが好ましく、より好ましくは1.0質量%以下である。また、重縮合ポリマーは、1種単独又は2種以上を組み合わせて用いてよい。 If the amount of the polycondensation polymer is too small, the above effect tends to be insufficient, and if it is too large, the elongation of the cosmetic on the skin may be deteriorated. The amount of the polycondensation polymer may be appropriately set according to the use of the cosmetic based on the above tendency, and is preferably 0.01% by mass or more, more preferably 0.05% by mass or more with respect to the cosmetic. is there. Moreover, it is preferable that the quantity of a polycondensation polymer is 2 mass% or less with respect to cosmetics, More preferably, it is 1.0 mass% or less. Moreover, you may use a polycondensation polymer individually by 1 type or in combination of 2 or more types.
本発明の化粧料は、前述の重縮合ポリマー粒子とともに、又は重縮合ポリマー粒子の代わりに、α,ω−ジ脂肪酸トリアミノ酸塩を含む。α,ω−ジ脂肪酸トリアミノ酸塩中の極性部分(特にアミド結合)が親水性を付与し、保水力を向上すると推測される。 The cosmetic of the present invention contains an α, ω-difatty acid triamino acid salt together with or in place of the polycondensation polymer particles described above. It is presumed that the polar part (particularly the amide bond) in the α, ω-difatty acid triamino acid salt imparts hydrophilicity and improves water retention.
また、本発明の化粧料は、べたつき感、潤い感、さっぱり感が向上する点で、α,ω−ジ脂肪酸トリアミノ酸塩が有する脂肪酸基同士の間にとりこまれる疎水性の低分子化合物を更に含む。なお、低分子化合物がとりこまれることは、その性質が公知であるという事実、又は公知でない場合にはα,ω−ジ脂肪酸トリアミノ酸塩に対する低分子化合物の量が異なる複数の試料を用意し、ある一定の比率までX線解析から得られるα,ω−ジ脂肪酸トリアミノ酸塩の層間距離が一定であり、それを超えるとX線解析から得られるα,ω−ジ脂肪酸トリアミノ酸塩の層間距離が増し、また、α,ω−ジ脂肪酸トリアミノ酸塩に取り込まれない低分子化合物が検出されるという結果により確認される(後述の図1参照)。なお、図1に示されるように、α,ω−ジ脂肪酸トリアミノ酸塩は、ミセルではなく、二層からなる閉鎖小胞体を形成しており、この構造により上記効果を奏する。 In addition, the cosmetic of the present invention further includes a hydrophobic low molecular weight compound that is incorporated between the fatty acid groups of the α, ω-difatty acid triamino acid salt in terms of improving the sticky feeling, moist feeling, and refreshing feeling. Including. Incorporation of low molecular weight compounds means the fact that their properties are known, or if not known, prepare multiple samples with different amounts of low molecular weight compounds relative to the α, ω-difatty acid triamino acid salt. The interlayer distance of α, ω-difatty acid triamino acid salt obtained from X-ray analysis is constant up to a certain ratio, and beyond that, the interlayer distance of α, ω-difatty acid triamino acid salt obtained from X-ray analysis exceeds This is confirmed by the result that the distance increases and a low molecular weight compound that is not incorporated into the α, ω-difatty acid triamino acid salt is detected (see FIG. 1 described later). As shown in FIG. 1, the α, ω-difatty acid triamino acid salt forms not a micelle but a closed vesicle composed of two layers, and this structure has the above-described effects.
α,ω−ジ脂肪酸トリアミノ酸塩は、一般式2で示される化合物を含んでよく、例えば、ジラウリン酸ジグルタミン酸リシンナトリウムを含んでよく、旭化成ケミカル社製「ペリセア」(商標)「L−30」等の市販品を用いてもよい。
式中、a及びbは、独立して、9以上15以下の炭素数を有し、XはNa又は水素である。
The α, ω-difatty acid triamino acid salt may contain a compound represented by the
In the formula, a and b independently have 9 to 15 carbon atoms, and X is Na or hydrogen.
α,ω−ジ脂肪酸トリアミノ酸塩の量は、過小であると上記効果が不十分になる場合がある一方、過大であると、べたつき感や皮膚上での延びが悪くなる場合がある。α,ω−ジ脂肪酸トリアミノ酸塩の量は、上記傾向に基づき化粧料の用途に応じて適宜設定されてよく、化粧料に対し0.005質量%以上であることが好ましく、より好ましくは0.01質量%以上、0.05質量%以上、0.1質量%以上、0.25質量%以上、1.0質量%以上である。α,ω−ジ脂肪酸トリアミノ酸塩の量は、化粧料に対し5質量%以下であることが好ましく、より好ましくは2.0質量%以下、1.0質量%以下である。また、α,ω−ジ脂肪酸トリアミノ酸塩は、1種単独又は2種以上を組み合わせて含まれてよい。 If the amount of the α, ω-difatty acid triamino acid salt is too small, the above effect may be insufficient. On the other hand, if the amount is too large, the stickiness and the elongation on the skin may be deteriorated. The amount of the α, ω-difatty acid triamino acid salt may be appropriately set according to the use of the cosmetic based on the above tendency, and is preferably 0.005% by mass or more based on the cosmetic, more preferably 0. 0.01 mass% or more, 0.05 mass% or more, 0.1 mass% or more, 0.25 mass% or more, or 1.0 mass% or more. The amount of the α, ω-difatty acid triamino acid salt is preferably 5% by mass or less, more preferably 2.0% by mass or less and 1.0% by mass or less with respect to the cosmetic. Further, the α, ω-difatty acid triamino acid salt may be contained singly or in combination of two or more.
疎水性の低分子化合物は、α,ω−ジ脂肪酸トリアミノ酸塩の構造によって適宜選択されてよく、例えば、コレステロール、セラミド、トコフェロール、ビタミンE、モノオレイン、ジオレイン、トリオレイン、及びそれらの誘導体の1種又は2種以上が挙げられる。中でも、それ自体の化粧効果にも優れる点で、コレステロール、セラミド、及びそれらの誘導体が好ましい。なお、誘導体は、置換基の導入、部分的構造の追加/削除などが施されたものであり、例えば、セラミドは脂肪酸基同士の間隔及び脂肪酸基の長さに対して大きい構造を有する場合が多く、その一部構造が削除された誘導体が好ましい場合がある。 The hydrophobic low molecular weight compound may be appropriately selected depending on the structure of the α, ω-difatty acid triamino acid salt. For example, cholesterol, ceramide, tocopherol, vitamin E, monoolein, diolein, triolein, and derivatives thereof 1 type or 2 types or more are mentioned. Among them, cholesterol, ceramide, and derivatives thereof are preferable because they are excellent in their cosmetic effects. Derivatives are those to which substituents are introduced, partial structures are added / deleted, etc. For example, ceramide may have a large structure with respect to the distance between fatty acid groups and the length of fatty acid groups. In many cases, a derivative from which a partial structure is deleted may be preferable.
低分子化合物及びα,ω−ジ脂肪酸トリアミノ酸塩の総量は、過小であるとさっぱり感、潤い感、べたつき感が良好でない場合があり、過大であるとべたつき感、皮膚上での延びが悪くなる場合がある。上記総量は、上記傾向に基づき化粧料の用途に応じて適宜設定されてよく、化粧料に対し0.0075質量%以上であることが好ましく、より好ましくは0.015質量%以上、0.075質量%以上、0.15質量%以上、0.20質量%以上、0.375質量%以上、0.525質量%以上、0.6質量%以上、0.75質量%以上である。上記総量は、化粧料に対し5質量%以下であることが好ましく、より好ましくは3.0質量%以下、1.5質量%以下、1.25質量%以下、1.125質量%以下、0.90質量%以下である。 If the total amount of the low molecular weight compound and the α, ω-difatty acid triamino acid salt is too small, the refreshing feeling, moisturizing feeling, and stickiness may not be good. If it is too large, the sticky feeling and the elongation on the skin will be poor. There is a case. Based on the above tendency, the total amount may be appropriately set according to the use of the cosmetic, and is preferably 0.0075% by mass or more, more preferably 0.015% by mass or more, 0.075% with respect to the cosmetic. It is mass% or more, 0.15 mass% or more, 0.20 mass% or more, 0.375 mass% or more, 0.525 mass% or more, 0.6 mass% or more, or 0.75 mass% or more. The total amount is preferably 5% by mass or less with respect to the cosmetic, more preferably 3.0% by mass or less, 1.5% by mass or less, 1.25% by mass or less, 1.125% by mass or less, 0 90% by mass or less.
低分子化合物に対するα,ω−ジ脂肪酸トリアミノ酸塩の質量比は、過小であるとさっぱり感、潤い感、べたつき感、皮膚上での延びが良好でない場合があり、過大であると潤い感の向上が不十分である場合がある。低分子化合物に対するα,ω−ジ脂肪酸トリアミノ酸塩の質量比は、1/3以上であることが好ましく、より好ましくは1/2.5以上、1/1.5以上である。低分子化合物に対するα,ω−ジ脂肪酸トリアミノ酸塩の質量比は、10/1以下であることが好ましく、より好ましくは5/1以下、2/1以下である。 When the mass ratio of α, ω-difatty acid triamino acid salt to low molecular weight compound is too small, refreshing feeling, moist feeling, stickiness, and elongation on the skin may not be good. The improvement may be insufficient. The mass ratio of the α, ω-difatty acid triamino acid salt to the low molecular compound is preferably 1/3 or more, more preferably 1 / 2.5 or more, and 1 / 1.5 or more. The mass ratio of the α, ω-difatty acid triamino acid salt to the low molecular compound is preferably 10/1 or less, more preferably 5/1 or less, and 2/1 or less.
低分子化合物として、セラミド誘導体及びコレステロールを併用する場合、セラミド誘導体に対するコレステロールの質量比は、1/4以上であることが好ましく、より好ましくは2/3以上、3/2以上、4/1以上である。また、セラミド誘導体の量は、潤い感の向上の点で、化粧料に対し0.025質量%以上であることが好ましく、より好ましくは0.05質量%以上である。 When a ceramide derivative and cholesterol are used in combination as the low molecular weight compound, the mass ratio of cholesterol to the ceramide derivative is preferably 1/4 or more, more preferably 2/3 or more, 3/2 or more, 4/1 or more. It is. In addition, the amount of the ceramide derivative is preferably 0.025% by mass or more, more preferably 0.05% by mass or more with respect to the cosmetic from the viewpoint of improving the moist feeling.
本発明で用いられる重縮合ポリマー粒子は、乳化安定性の点でより優れ、また化粧料に高粘性を与えやすい一方、閉鎖小胞体は、化粧料に低粘性を与えやすく、また内相の粒子径を小さくすることで化粧料の透明性を向上しやすい。このため、特に限定されないが、乳液状、クリーム状、ゲル状の化粧料では重縮合ポリマー粒子が好ましく、化粧水、美容液、パック等の化粧料では閉鎖小胞体が好ましい傾向がある。また、特に限定されないが、水に対する界面張力の高い油を多量に用いるときには、重縮合ポリマー粒子が好ましい。 The polycondensation polymer particles used in the present invention are more excellent in terms of emulsion stability and tend to give cosmetics a high viscosity, while closed vesicles tend to give cosmetics a low viscosity and are particles in the internal phase. It is easy to improve the transparency of cosmetics by reducing the diameter. For this reason, although not particularly limited, polycondensation polymer particles are preferable for emulsions, creams, and gels, and closed vesicles tend to be preferable for cosmetics such as lotions, cosmetics, and packs. Although not particularly limited, polycondensation polymer particles are preferred when a large amount of oil having a high interfacial tension with respect to water is used.
本発明の化粧料は、乳化状態を維持し、又は振とう等で容易に乳化状態を形成できるものであり、乳化状態においてO/W型エマルション構造を有する。 The cosmetic of the present invention can maintain an emulsified state or can easily form an emulsified state by shaking or the like, and has an O / W emulsion structure in the emulsified state.
油相は、従来化粧料において公知の油剤を含んでよく、本発明では、油相の水に対する大きい界面張力にも耐えられることから、幅広い油剤を使用することができる。具体的には、ジメチルポリシロキサン、トリメチルシロキサン、メチルフェニルシロキサン、環状シリコーン等のシリコーン、スクワラン、パラフィン等の炭化水素、パルミチン酸イソプロピル、ミリスチン酸イソプロピル、ミリスチン酸ミリスチル、ミリスチン酸イソステアリル、ミリスチン酸オクチルドデシル、トリエチルヘキサン酸グリセリル、トリエチルヘキサノイン、ジエチルヘキサン酸ネオペンチルグリコール、トリ(カプリル酸・カプリン酸)グリセリル、エチルヘキサン酸セチル、ぶどう種子油、ローズヒップ油、ヒマワリ油、オリーブ油、アボカド油、マカダミアナッツ油、メドホーム油、シア脂、ホホバ油、ミツロウ、水素添加パーム油、ステアリン酸コレステリル、フィトステロール、トリミリスチン酸グリセリル、トリステアリン酸グリセリル、ヘキサ(ヒドロキシステアリン酸)ジペンタエリスリトール、イソノナン酸イソノニル、イソノナン酸イソトリデシル、トリオクタノイン、テトラオクタン酸ペンタエリスリトール、リンゴ酸ジイソステアリル等、ラウロイルサルコシンイソプロピル、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、ラウロイルグルタミン酸ジ(コレステリル/オクチルドデシル)等のアミドエステル等のエステル等の1種又は2種以上が挙げられる。 The oil phase may contain a known oil agent in conventional cosmetics. In the present invention, the oil phase can withstand a large interfacial tension of water in the oil phase, so that a wide range of oil agents can be used. Specifically, silicones such as dimethylpolysiloxane, trimethylsiloxane, methylphenylsiloxane, cyclic silicone, hydrocarbons such as squalane and paraffin, isopropyl palmitate, isopropyl myristate, myristyl myristate, isostearyl myristate, octyl myristate Dodecyl, glyceryl triethylhexanoate, triethylhexanoin, neopentyl glycol diethylhexanoate, glyceryl tri (caprylate / caprate), cetyl ethylhexanoate, grape seed oil, rosehip oil, sunflower oil, olive oil, avocado oil, macadamia Nut oil, medhome oil, shea fat, jojoba oil, beeswax, hydrogenated palm oil, cholesteryl stearate, phytosterol, glyceryl trimyristate, Glyceryl ristearate, hexa (hydroxystearic acid) dipentaerythritol, isononyl isononanoate, isotridecyl isononanoate, trioctanoin, pentaerythritol tetraoctanoate, diisostearyl malate, lauroyl sarcosine isopropyl, lauroyl glutamate di (phytosteryl / 1 type or 2 types or more, such as ester, such as amide ester, such as octyldodecyl) and lauroyl glutamic acid di (cholesteryl / octyldodecyl).
油相は、水に対して25mN/m以上の平均界面張力を有する油からなってよい。上記平均界面張力は、30mN/m以上であることがより好ましい。なお、平均界面張力は、化粧料から回収した油相成分について、懸滴法により測定される。中でも、大きい界面張力を与えることが知られるスクワランが、安全性に優れる点で好ましく用いられる。他の油剤については、従来周知(例えば、特開2007−70304号公報)であるため、省略する。油相は、特に限定されないが、化粧料に対し5質量%〜95質量%の量であってよく、具体的には1.0〜40質量%である。 The oil phase may consist of an oil having an average interfacial tension of 25 mN / m or more with respect to water. The average interfacial tension is more preferably 30 mN / m or more. The average interfacial tension is measured by the hanging drop method for the oil phase component recovered from the cosmetic. Among these, squalane, which is known to give a large interfacial tension, is preferably used because it is excellent in safety. Other oil agents are well known in the art (for example, Japanese Patent Application Laid-Open No. 2007-70304), and are therefore omitted. Although an oil phase is not specifically limited, The quantity of 5 mass%-95 mass% with respect to cosmetics may be sufficient, and it is 1.0-40 mass% specifically ,.
水相は、従来化粧料において公知の水溶性成分を含んでよく、本発明では、幅広い水溶性成分を使用することができる。このような水溶性成分については、従来周知(例えば、特開2007−70304号公報)であるため、省略する。水相は、特に限定されないが、化粧料に対し5質量%〜95質量%の量であってよい。 The aqueous phase may contain water-soluble ingredients known in conventional cosmetics, and a wide range of water-soluble ingredients can be used in the present invention. Such a water-soluble component is well known in the art (for example, Japanese Patent Application Laid-Open No. 2007-70304), and is therefore omitted. Although a water phase is not specifically limited, The quantity of 5 mass%-95 mass% with respect to cosmetics may be sufficient.
<任意成分>
本発明に係る化粧料は、さっぱり感、べたつき感、リッチ感(コク)が向上する点で、高級アルコールを更に含有することが好ましい。高級アルコールは液晶を形成し、皮膚上(体温)で油脂をとりこんで固まるため、さっぱり感が向上し、べたつき感が低下するものと推測される。高級アルコールは、直鎖又は分岐鎖のいずれの構造を有してもよく、炭素数が16以上、好ましくは18以上、20以上、22以上であってよい。なお、上記機構から、高級アルコールの平均融点は、38℃以上であることが好ましく、より好ましくは50℃以上、具体的には54〜73℃であってよい。
<Optional component>
The cosmetic according to the present invention preferably further contains a higher alcohol in terms of improving the refreshing feeling, stickiness, and richness (brightness). Higher alcohols form liquid crystals and take in oils and fats on the skin (body temperature) and harden. Therefore, it is estimated that the refreshing feeling is improved and the sticky feeling is lowered. The higher alcohol may have a linear or branched structure, and may have 16 or more carbon atoms, preferably 18 or more, 20 or more, or 22 or more. From the above mechanism, the average melting point of the higher alcohol is preferably 38 ° C. or higher, more preferably 50 ° C. or higher, specifically 54 to 73 ° C.
高級アルコールとしては、イソステアリン酸、イソパルミチン酸、オレイン酸、パルミトレイン酸、リノール酸、リシノレイン酸等の脂肪酸、ラノリン、ラノリンアルコール、水素添加ラノリンアルコール等のラノリン誘導体、セタノール、ヘキシルデカノール、イソステアリルアルコール、ステアリルアルコール、オクチルドデカノール、オレイルアルコール、セトステアリルアルコール、ベヘニルアルコール等の1種又は2種以上が挙げられる。中でも、上記効果に優れる点で、ステアリルアルコール及び/又はベヘニルアルコールが好ましい。 As higher alcohols, fatty acids such as isostearic acid, isopalmitic acid, oleic acid, palmitoleic acid, linoleic acid, ricinoleic acid, lanolin derivatives such as lanolin, lanolin alcohol, hydrogenated lanolin alcohol, cetanol, hexyldecanol, isostearyl alcohol, stearyl 1 type (s) or 2 or more types, such as alcohol, octyldodecanol, oleyl alcohol, cetostearyl alcohol, behenyl alcohol, are mentioned. Among these, stearyl alcohol and / or behenyl alcohol are preferable in terms of excellent effects.
高級アルコールの量は、過小であると上記効果が不十分である場合があり、過大であると皮膚上での延びが十分に向上しない場合がある。高級アルコールの量は、化粧料に対し0.1質量%以上であってよく、好ましくは0.5質量%以上であり、10質量%以下であってよく、好ましくは5質量%以下、3質量%以下である。 If the amount of the higher alcohol is too small, the above effect may be insufficient, and if it is too large, the elongation on the skin may not be sufficiently improved. The amount of the higher alcohol may be 0.1% by mass or more, preferably 0.5% by mass or more, may be 10% by mass or less, preferably 5% by mass or less, 3% by mass with respect to the cosmetic. % Or less.
ステアリルアルコール及びベヘニルアルコールを併用することは、べたつき感、リッチ感の向上の点で好ましい。この場合、ベヘニルアルコールに対するステアリルアルコールの質量比は、1/10以上であってよく、好ましくは6/24以上、16/14以上、18/12以上であり、20/1以下であってよく、好ましくは10/1以下、1/2以下である。 The combined use of stearyl alcohol and behenyl alcohol is preferable in terms of improvement in stickiness and richness. In this case, the mass ratio of stearyl alcohol to behenyl alcohol may be 1/10 or more, preferably 6/24 or more, 16/14 or more, 18/12 or more, and may be 20/1 or less, preferably Is 10/1 or less and 1/2 or less.
本発明の化粧料は、さっぱり感、べたつき感、及びリッチ感(コク)が向上する点で、モノ脂肪酸グリセリンエーテル(ただし、脂肪酸の炭素数は16以上である)を更に含有することが好ましい。モノ脂肪酸グリセリンエーテルは油相の粒子径を小さくし、分散性を高めることで、上記効果を奏すると推測される。 The cosmetic of the present invention preferably further contains a mono fatty acid glycerin ether (however, the number of carbon atoms of the fatty acid is 16 or more) in terms of improving the refreshing feeling, stickiness, and richness (richness). Mono fatty acid glycerin ether is presumed to have the above effect by reducing the particle size of the oil phase and increasing the dispersibility.
モノ脂肪酸グリセリンエーテルとしては、イソステアリルグリセリルエーテル、キミルアルコール、セラキルアルコール、バチルアルコール等の1種又は2種以上が挙げられる。中でも、さっぱり感、べたつき感、リッチ感の向上の点で、バチルアルコールが好ましい。 As mono-fatty acid glycerin ether, 1 type (s) or 2 or more types, such as an isostearyl glyceryl ether, a chimyl alcohol, a ceralkyl alcohol, a batyl alcohol, are mentioned. Of these, batyl alcohol is preferred in terms of improving a refreshing feeling, stickiness, and rich feeling.
モノ脂肪酸グリセリンエーテルの量は、過小であると上記効果が不十分である場合があり、過大であると皮膚上での延びが十分に向上しない場合がある。モノ脂肪酸グリセリンエーテルの量は、化粧料に対し0.05質量%以上であってよく、好ましくは0.1質量%以上、0.2質量%以上、0.3質量%以上であり、10質量%以下であってよく、好ましくは1.0質量%以下、0.75質量%以下、0.5質量%以下である。 If the amount of mono-fatty acid glycerin ether is too small, the above effects may be insufficient, and if it is too large, the elongation on the skin may not be sufficiently improved. The amount of the mono fatty acid glycerin ether may be 0.05% by mass or more, preferably 0.1% by mass or more, 0.2% by mass or more, 0.3% by mass or more, and 10% by mass with respect to the cosmetic. % Or less, preferably 1.0% by mass or less, 0.75% by mass or less, and 0.5% by mass or less.
モノ脂肪酸グリセリンエーテルは、単独で用いてもよいが、皮膚上での延び、フレーキングを向上する点で、高級アルコールと併用することが好ましい。併用する場合、両者の有用性をバランス良くとりいれる観点で、高級アルコール及びモノ脂肪酸グリセリンエーテルの総量は、化粧料に対し0.25質量%以上であってよく、好ましくは0.5質量%以上、1.0質量%以上であり、10質量%以下であってよく、好ましくは7.5質量%以下、5.0質量%以下である。 Mono fatty acid glycerin ether may be used alone, but is preferably used in combination with a higher alcohol in terms of extending on the skin and improving flaking. When used in combination, the total amount of the higher alcohol and mono fatty acid glycerin ether may be 0.25% by mass or more, preferably 0.5% by mass or more, based on the cosmetics, from the viewpoint of taking a balance between the usefulness of both. It is 1.0 mass% or more, may be 10 mass% or less, Preferably it is 7.5 mass% or less, and 5.0 mass% or less.
モノ脂肪酸グリセリンエーテルに対する高級アルコールの質量比は、25/5以上であることが好ましく、より好ましくは26/4以上であり、29/1以下であってよく、好ましくは27/3以下である。 The mass ratio of the higher alcohol to the mono fatty acid glycerin ether is preferably 25/5 or more, more preferably 26/4 or more, may be 29/1 or less, and preferably 27/3 or less.
本発明の化粧料は、その他、防腐剤、増粘剤等の従来公知の任意成分を幅広く含有してよい(例えば、特開2007−8901号公報)。具体的に、本発明の化粧料は、乳化性能をより向上し得る点で界面活性剤を更に含有してもよいが、界面活性剤の有無にかかわらず十分な乳化性能が得られる場合が多いことから、界面活性剤を実質的に含有しなくてもよい。「実質的に含有しない」とは、乳化性能に差異を与えない程度の僅少量を指し、具体的には化粧料に対して0.1質量%以下、0.08質量%以下、0.07質量%以下、0.06質量%以下、0.05質量%以下、0.04質量%以下、0.02質量%以下、0.02質量%以下、0.01質量%以下、0.005質量%以下、0.001質量%以下である。 In addition, the cosmetic of the present invention may contain a wide variety of conventionally known optional components such as preservatives and thickeners (for example, JP-A-2007-8901). Specifically, the cosmetic of the present invention may further contain a surfactant in that the emulsification performance can be further improved, but sufficient emulsification performance is often obtained regardless of the presence or absence of the surfactant. Therefore, the surfactant may not be substantially contained. “Substantially free” refers to a small amount that does not give a difference in emulsification performance. Specifically, it is 0.1% by mass or less, 0.08% by mass or less, 0.07% by mass with respect to cosmetics. % By mass or less, 0.06% by mass or less, 0.05% by mass or less, 0.04% by mass or less, 0.02% by mass or less, 0.02% by mass or less, 0.01% by mass or less, 0.005% by mass % Or less and 0.001 mass% or less.
本発明の化粧料は、液状、乳液状、クリーム状、固形状、ゲル状等の種々の形態をとってよい。また、本発明の化粧料は、前述のような優れた特性を有するため、ファンデーション、白粉、口紅、アイシャドウ、チーク、マスカラ、アイライナー等のメイクアップ化粧料や、サンスクリーン剤、下地クリーム、ヘアクリーム等の皮膚又は毛髪に適用される種々の用途に適用されてよい。 The cosmetic of the present invention may take various forms such as liquid, emulsion, cream, solid, and gel. Further, since the cosmetic of the present invention has the above-described excellent characteristics, makeup cosmetics such as foundation, white powder, lipstick, eye shadow, teak, mascara, eyeliner, sunscreen agent, foundation cream, You may apply to the various uses applied to skin or hair, such as a hair cream.
<製造方法>
本発明に係る化粧料の製造方法は、水酸基を有しかつ一部に疎水性基が導入された重縮合ポリマー粒子が分散した水分散液と、油成分と、を混合し、水相及び油相を互いに乳化させる工程を有する。水相及び油相の混合比や混合条件は、従来公知であるため、省略する。
<Manufacturing method>
The method for producing a cosmetic according to the present invention comprises mixing an aqueous dispersion in which polycondensation polymer particles having a hydroxyl group and partly having a hydrophobic group introduced therein are dispersed, and an oil component. Having the steps of emulsifying the phases together. Since the mixing ratio and mixing conditions of the water phase and the oil phase are conventionally known, they are omitted.
水酸基を有しかつ一部に疎水性基が導入された重縮合ポリマー粒子が分散した水分散液は、その重縮合ポリマーの粉末を、水に分散し加熱して重縮合ポリマー粒子を水中に分離した後、冷却することで行われることが好ましい。 An aqueous dispersion in which polycondensation polymer particles having a hydroxyl group and a partly introduced hydrophobic group are dispersed is dispersed in water and heated to separate the polycondensation polymer particles in water. Then, it is preferably performed by cooling.
高級アルコールを用いる場合、高級アルコールを水分散液に添加し、高級アルコールの融点以上の温度において溶解させ、融点以下の温度へと冷却した後、油成分を混合することが好ましい。これにより、高級アルコールが微細に水相に分散し、高級アルコールによる効果が最大化される。なお、高級アルコールの添加は、油成分を混合した後であってもよい。 When using a higher alcohol, it is preferable to add the higher alcohol to the aqueous dispersion, dissolve it at a temperature higher than the melting point of the higher alcohol, cool to a temperature lower than the melting point, and then mix the oil component. Thereby, the higher alcohol is finely dispersed in the aqueous phase, and the effect of the higher alcohol is maximized. The higher alcohol may be added after the oil component is mixed.
α,ω−ジ脂肪酸トリアミノ酸塩を用いる場合、α,ω−ジ脂肪酸トリアミノ酸塩を水に分散させた後、油成分を混合することが好ましいが、油成分を混合した後にα,ω−ジ脂肪酸トリアミノ酸塩を添加してもよい。疎水性の低分子化合物を併用する場合、低分子化合物をpH3.5〜4.5の条件下で水に分散させた後、pHを6.0〜7.0に戻し、水分散液に添加する工程を更に有することが好ましい。これにより、低分子化合物がα,ω−ジ脂肪酸トリアミノ酸塩の脂肪酸基同士の間にとりこまれやすい。なお、pH3.5〜4.5はα,ω−ジ脂肪酸トリアミノ酸塩内のカルボキシル基のpKa近辺である。 When α, ω-difatty acid triamino acid salt is used, it is preferable to disperse the α, ω-difatty acid triamino acid salt in water and then mix the oil component. However, after mixing the oil component, α, ω- A difatty acid triamino acid salt may be added. When using a hydrophobic low molecular weight compound, after dispersing the low molecular weight compound in water under the conditions of pH 3.5 to 4.5, the pH is returned to 6.0 to 7.0 and added to the aqueous dispersion. It is preferable to further include the step of performing. Thereby, a low molecular weight compound tends to be taken in between the fatty acid groups of the α, ω-difatty acid triamino acid salt. In addition, pH 3.5-4.5 is pKa vicinity of the carboxyl group in alpha, omega-di fatty acid triamino acid salt.
本発明に係る化粧料の製造方法は、乳化物を化粧料に加工する工程を有してよい。加工は、特に限定されず、適宜行えばよい。具体的に、加工する工程は、乳化物を水で希釈する工程を有してよい。界面活性剤の場合、O/Wエマルションに水を加えると、油相に可逆的に吸着していた界面活性剤が脱離し、乳化状態が不安定化してしまう。しかし、本発明では、重縮合ポリマー粒子が油に不可逆的に付着して乳化するため、希釈の有無にかかわらず、乳化状態が安定である。これにより、乳化物を油が高濃度であるように製造しておき、乳化物を流通等し、化粧料の製造時に適宜希釈するという化粧料の製造が可能になる。 The manufacturing method of the cosmetics which concern on this invention may have the process of processing an emulsion into cosmetics. Processing is not particularly limited, and may be performed as appropriate. Specifically, the processing step may include a step of diluting the emulsion with water. In the case of a surfactant, when water is added to the O / W emulsion, the surfactant that has been reversibly adsorbed to the oil phase is desorbed and the emulsified state becomes unstable. However, in the present invention, since the polycondensation polymer particles adhere irreversibly to the oil and emulsify, the emulsified state is stable regardless of the presence or absence of dilution. This makes it possible to produce a cosmetic product in which the emulsion is produced so that the oil has a high concentration, the emulsion is distributed, etc., and appropriately diluted when the cosmetic product is produced.
<実施例1> 乳化粒子
水59.75質量部に表1に示す成分0.25質量部を加えて撹拌した。この撹拌液60質量部を80℃に加熱し、スクワラン40質量部を添加し、ホモミキサーにより10000rpm、80℃、10分間に亘って撹拌した後、冷却し、O/Wエマルション型の乳化物を調製した。この乳化物を顕微鏡で観察し、油滴の粒子径の範囲を大まかに求めた。また、乳化物の外観(油膜や視認可能な程の油滴)を目視で観察した結果、及び皮膚に適用したときのべたつき感をパネリストに評価させた結果を、表1に併せて示す。なお、油膜及び油滴の評価では、×から◎の順で、油膜及び油滴が多いものから、見られないものである。また、べたつき感の評価では、×から◎の順で、べたつき感がひどいものから、ないものである。
<Example 1> Emulsified particles To 59.75 parts by mass of water, 0.25 parts by mass of the components shown in Table 1 were added and stirred. 60 parts by mass of this stirring liquid is heated to 80 ° C., 40 parts by mass of squalane is added, and after stirring for 10 minutes at 10,000 rpm and 80 ° C. with a homomixer, the mixture is cooled to obtain an O / W emulsion type emulsion. Prepared. This emulsion was observed with a microscope, and the range of the particle diameter of the oil droplet was roughly determined. Table 1 also shows the results of visually observing the appearance of the emulsion (oil film and visible oil droplets) and the panelist's evaluation of stickiness when applied to the skin. In the evaluation of the oil film and the oil droplets, the oil film and the oil droplets are not observed in the order of x to. Also, in the evaluation of the stickiness, the stickiness is in the order of x to ◎, and the stickiness is not so.
表1に示されるように、疎水基(ステアリル基)が導入されたヒドロキシプロピルメチルセルロースが、外観及びべたつき感の点で顕著に優れていた。そこで、疎水基(ステアリル基)が導入されたヒドロキシプロピルメチルセルロースの配合量を、表2〜5に示すように変更した点を除き、上と同様に乳化物を調製した。また、潤い感及び皮膚上での延びについても評価を行った。なお、潤い感の評価では、×〜◎の順に、潤い感がないもの、から優れたものである。皮膚上での延びの評価では、×〜◎の順に、延びないものから、延びるものである。粘性の評価では、×〜◎の順に、粘性が低いものから、高いものである。 As shown in Table 1, hydroxypropyl methylcellulose having a hydrophobic group (stearyl group) introduced therein was remarkably excellent in terms of appearance and stickiness. Therefore, an emulsion was prepared in the same manner as above except that the amount of hydroxypropylmethylcellulose into which a hydrophobic group (stearyl group) was introduced was changed as shown in Tables 2-5. In addition, the feeling of moisture and the elongation on the skin were also evaluated. In addition, in the evaluation of a moist feeling, it is excellent from the thing which does not have a moist feeling in order of x- (double-circle). In the evaluation of the elongation on the skin, it extends from the one not extending in the order of x to 〜. In the evaluation of the viscosity, the viscosity is low to high in the order of x to ◎.
<実施例2> α,ω−ジ脂肪酸トリアミノ酸塩
α,ω−ジ脂肪酸トリアミノ酸塩である「ペリセア L−30」(商標)を併用した点を除き、実施例1と同様の手順で乳化物を調製した。この結果を表6に示す。
<Example 2> α, ω-difatty acid triamino acid salt Emulsification in the same procedure as in Example 1 except that “Perisea L-30” (trademark) which is an α, ω-difatty acid triamino acid salt is used in combination. A product was prepared. The results are shown in Table 6.
表6に示されるように、α,ω−ジ脂肪酸トリアミノ酸塩であるジラウロイルグルタミン酸リジンナトリウムが、べたつき感、潤い感及びさっぱり感の点で顕著に優れていた。そこで、α,ω−ジ脂肪酸トリアミノ酸塩の配合量を、表7に示すように変更した点を除き、上と同様に乳化物を調製した。 As shown in Table 6, dilauroyl glutamate lysine sodium, which is an α, ω-difatty acid triamino acid salt, was remarkably superior in terms of stickiness, moisturization and refreshment. Accordingly, an emulsion was prepared in the same manner as above except that the blending amount of the α, ω-difatty acid triamino acid salt was changed as shown in Table 7.
また、コレステロール及び「ソフケアセラミドSL−E」(花王社製;以下、「擬似セラミド」と表記)を表8〜12に示される比率及び量で、α,ω−ジ脂肪酸トリアミノ酸塩と併用した点を除き、上と同様の手順で乳化物を調製した。なお、いずれのpHも6.0とした。 Further, cholesterol and “Sofcare Ceramide SL-E” (manufactured by Kao Corporation; hereinafter referred to as “pseudo ceramide”) are used in combination with α, ω-difatty acid triamino acid salt in the ratios and amounts shown in Tables 8-12. Except for the above, an emulsion was prepared in the same procedure as above. In addition, all pH was 6.0.
また、表9のいくつかの例で得た化粧料について、X線解析を行い、その結果得られた2θ値に基づき、検出された物質の大きさを算出した。この結果を図1に示す。図1において、横軸は、α,ω−ジ脂肪酸トリアミノ酸塩及びコレステロールの総量に対するコレステロールの比率(モル分率)であり、縦軸は検出物質の大きさを示す。図1に示されるように、コレステロールのモル分率が0.4以下の範囲では、α,ω−ジ脂肪酸トリアミノ酸塩の側鎖同士で囲まれた空間にコレステロール(α,ω−ジ脂肪酸トリアミノ酸塩の側鎖の長さの2倍より短い)が1つ配置されている距離(α,ω−ジ脂肪酸トリアミノ酸塩の側鎖の長さの2倍と同等)が観察される一方、0.4以上の範囲では、α,ω−ジ脂肪酸トリアミノ酸塩の側鎖同士で囲まれた空間にコレステロールが2つ配置されていると推測される距離(α,ω−ジ脂肪酸トリアミノ酸塩の側鎖の2倍より長い)と、コレステロール単分子と推測される距離が観察された。このことから、コレステロールがα,ω−ジ脂肪酸トリアミノ酸塩の側鎖同士の間にとりこまれていることが分かった。 Further, X-ray analysis was performed on the cosmetics obtained in some examples in Table 9, and the size of the detected substance was calculated based on the 2θ value obtained as a result. The result is shown in FIG. In FIG. 1, the horizontal axis represents the ratio (molar fraction) of cholesterol to the total amount of α, ω-difatty acid triamino acid salt and cholesterol, and the vertical axis represents the size of the detection substance. As shown in FIG. 1, when the mole fraction of cholesterol is in the range of 0.4 or less, cholesterol (α, ω-difatty acid trioxide is contained in the space surrounded by side chains of α, ω-difatty acid triamino acid salt. While a distance (equivalent to twice the length of the side chain of the α, ω-difatty acid triamino acid salt) is placed, which is less than twice the length of the side chain of the amino acid salt) is observed, In the range of 0.4 or more, the distance (α, ω-difatty acid triamino acid salt) that is estimated that two cholesterols are arranged in the space surrounded by the side chains of the α, ω-difatty acid triamino acid salt. And a distance presumed to be a cholesterol single molecule was observed. From this, it was found that cholesterol was incorporated between the side chains of the α, ω-difatty acid triamino acid salt.
<実施例3> 高級アルコール、モノ脂肪酸グリセリンエーテル
表13に示す高級アルコールを併用した点を除き、実施例1と同様の手順で乳化物を調製した。この結果を表13に示す。
<Example 3> Higher alcohol, mono fatty acid glycerin ether An emulsion was prepared in the same procedure as in Example 1 except that the higher alcohol shown in Table 13 was used in combination. The results are shown in Table 13.
表13に示されるように、高級アルコール、特に炭素数18以上の高級アルコールを併用することで、さっぱり感、べたつき感、リッチ感が向上することが分かった。また、モノ脂肪酸グリセリンエーテルを併用することで、さっぱり感、べたつき感、リッチ感が顕著に向上することが分かった。ただし、皮膚上の延び及びフレーキングの点で両者とも多少の問題を有する。そこで、α,ω−ジ脂肪酸トリアミノ酸塩及びモノ脂肪酸グリセリンエーテルの配合量を、表14〜18に示すように変更した点を除き、上と同様に乳化物を調製した。 As shown in Table 13, it was found that the use of higher alcohols, particularly higher alcohols having 18 or more carbon atoms, improved the refreshing feeling, stickiness, and richness. Moreover, it turned out that a refreshing feeling, stickiness, and a rich feeling improve notably by using mono-fatty acid glycerol ether together. However, both have some problems in terms of skin stretch and flaking. Therefore, an emulsion was prepared in the same manner as above except that the blending amounts of α, ω-difatty acid triamino acid salt and mono fatty acid glycerin ether were changed as shown in Tables 14-18.
<実施例4>
各成分を表22以降に示すとおりとした点を除き、実施例1と同様の手順で乳化物を調製した。なお、シリコーンKF−56はメチルフェニルシロキサン、NJcol200Aはオクチルドデカノール、エルデュウPS−203はラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、TIOはトリエチルヘキサノイン、シリコーンSH−200はジメチルポリシロキサン、エルデュウSL−205はラウロイルサルコシンイソプロピル
<Example 4>
An emulsion was prepared in the same procedure as in Example 1 except that each component was as shown in Table 22 and later. Silicone KF-56 is methyl phenyl siloxane, NJcol 200A is octyldodecanol, Erdu PS-203 is dilauroyl glutamate (phytosteryl / octyldodecyl), TIO is triethylhexanoin, Silicone SH-200 is dimethylpolysiloxane, Erdu SL- 205 is lauroyl sarcosine isopropyl
表22〜25に示されるように、重縮合ポリマー粒子の代わりに閉鎖小胞体を含む化粧料も、優れた特性を示した。中でも、重縮合ポリマーの量が少ない化粧料では、内相の粒子径がより小さく、透明性が高い傾向があった。なお、きしみが高い化粧料は、男性向け化粧料に有用であり、こくが低く、たれ落ちしやすい化粧料は、化粧水に有用であり、こくが高く、たれ落ちしにくい化粧料は美容液に有用である。 As shown in Tables 22-25, cosmetics containing closed vesicles instead of polycondensation polymer particles also showed excellent properties. Among these, cosmetics with a small amount of polycondensation polymer tend to have a smaller inner phase particle size and higher transparency. Cosmetics with high creaking are useful for cosmetics for men, and cosmetics with low body and easy to sag are useful for skin lotions, and cosmetics with high body and low sag are cosmetic liquids. Useful for.
Claims (20)
(B)油相、並びに
(C−2)α,ω−ジ脂肪酸トリアミノ酸塩及び前記α,ω−ジ脂肪酸トリアミノ酸塩が有する脂肪酸基同士の間にとりこまれる疎水性の低分子化合物を有する閉鎖小胞体を含み、
バチルアルコールをさらに含有する化粧料。 (A) water phase,
(B) having an oil phase, and (C-2) an α, ω-difatty acid triamino acid salt and a hydrophobic low molecular weight compound incorporated between the fatty acid groups of the α, ω-difatty acid triamino acid salt. a closed endoplasmic reticulum seen including,
Cosmetics further containing batyl alcohol .
(B)油相、並びに
(C−1)水酸基を有しかつ一部に疎水性基が導入された重縮合ポリマー粒子、及び(C−2)α,ω−ジ脂肪酸トリアミノ酸塩及び前記α,ω−ジ脂肪酸トリアミノ酸塩が有する脂肪酸基同士の間にとりこまれる疎水性の低分子化合物を有する閉鎖小胞体を含む化粧料。 (A) water phase,
(B) an oil phase, (C-1) a polycondensation polymer particle having a hydroxyl group and having a hydrophobic group partially introduced therein, and (C-2) an α, ω-difatty acid triamino acid salt and the α , A cosmetic comprising a closed endoplasmic reticulum having a hydrophobic low-molecular compound incorporated between fatty acid groups of a ω-difatty acid triamino acid salt.
式中、Rは、各々独立して、水素、メチル、−[R’O]mH(式中、R’はアルキル基、mは1以上の整数である)、又は−R’’OCpH2p+1(式中、R’’は側鎖に水酸基を有するアルキル基、pは8以上22以下の整数である)であり、nは100以上の整数である。 The cosmetic according to claim 5, wherein the polycondensation polymer in which a hydrophobic group is introduced into a part of the hydroxyl group includes a compound represented by the general formula 1.
In the formula, each R is independently hydrogen, methyl, — [R′O] m H (where R ′ is an alkyl group, m is an integer of 1 or more), or —R ″ OC p. H 2p + 1 (wherein R ″ is an alkyl group having a hydroxyl group in the side chain, p is an integer of 8 to 22, and n is an integer of 100 or more).
式中、a及びbは、独立して、9以上15以下の炭素数を有し、XはNa又は水素である。 The cosmetic according to any one of claims 1 to 6, wherein the α, ω-difatty acid triamino acid salt contains a compound represented by Formula 2.
In the formula, a and b independently have 9 to 15 carbon atoms, and X is Na or hydrogen.
α,ω−ジ脂肪酸トリアミノ酸塩及び疎水性の低分子化合物をpH3.5〜4.5の条件下で水に分散させた後、pHを6.0〜7.0に戻し、前記水分散液に添加することで、前記閉鎖小胞体を調製する工程を更に有する化粧料の製造方法。 Polycondensation polymer particles having a hydroxyl group and partially having a hydrophobic group introduced, and / or between the fatty acid groups of the α, ω-difatty acid triamino acid salt and the α, ω-difatty acid triamino acid salt and aqueous dispersion closed vesicles are dispersed with incorporated hydrophobic low molecular weight compound, an oil component, were mixed, the water and oil phases have a process to emulsify each other,
After the α, ω-difatty acid triamino acid salt and the hydrophobic low molecular weight compound are dispersed in water under the conditions of pH 3.5 to 4.5, the pH is returned to 6.0 to 7.0, and the water dispersion by adding to the liquid, said closure cosmetic method for producing further have a step of preparing the vesicles.
20. The method according to claim 18 or 19, wherein a higher alcohol is added to the aqueous dispersion, dissolved at a temperature equal to or higher than the melting point of the higher alcohol, cooled to a temperature equal to or lower than the melting point, and then the oil component is mixed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013034363A JP6003000B2 (en) | 2012-04-06 | 2013-02-25 | Cosmetics and method for producing cosmetics |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012087955 | 2012-04-06 | ||
JP2012087955 | 2012-04-06 | ||
JP2013034363A JP6003000B2 (en) | 2012-04-06 | 2013-02-25 | Cosmetics and method for producing cosmetics |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2013231023A JP2013231023A (en) | 2013-11-14 |
JP2013231023A5 JP2013231023A5 (en) | 2015-07-02 |
JP6003000B2 true JP6003000B2 (en) | 2016-10-05 |
Family
ID=49677822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013034363A Active JP6003000B2 (en) | 2012-04-06 | 2013-02-25 | Cosmetics and method for producing cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6003000B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5656272B1 (en) * | 2014-02-21 | 2015-01-21 | 学校法人神奈川大学 | Cleansing composition and cleansing article |
JP6426363B2 (en) * | 2014-03-30 | 2018-11-21 | 小林製薬株式会社 | Oil-in-water emulsion composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0987130A (en) * | 1995-09-21 | 1997-03-31 | Shiseido Co Ltd | Emulsified composition |
JP4947267B2 (en) * | 2006-03-09 | 2012-06-06 | 学校法人神奈川大学 | Cosmetics and method for producing the same |
JP5094041B2 (en) * | 2006-05-10 | 2012-12-12 | 旭化成ケミカルズ株式会社 | Liposomes and liposome preparations |
JP4891695B2 (en) * | 2006-06-16 | 2012-03-07 | ポーラ化成工業株式会社 | Ceramide-containing topical skin preparation |
JP5254645B2 (en) * | 2007-03-13 | 2013-08-07 | 株式会社コーセー | Vesicle composition and external preparation for skin containing the vesicle composition |
WO2008149601A1 (en) * | 2007-05-29 | 2008-12-11 | Pola Chemical Industries Inc. | Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
JP5657191B2 (en) * | 2007-06-19 | 2015-01-21 | ポーラ化成工業株式会社 | Vesicle and topical skin preparation containing the same |
JP2009256253A (en) * | 2008-04-17 | 2009-11-05 | Pola Chem Ind Inc | Microsphere for cosmetic and cosmetic containing the same |
JP5658953B2 (en) * | 2009-10-01 | 2015-01-28 | 花王株式会社 | Method for producing hair cosmetics |
JP6082933B2 (en) * | 2010-09-14 | 2017-02-22 | 学校法人神奈川大学 | Emulsifier and method for producing the same, and method for producing emulsion |
-
2013
- 2013-02-25 JP JP2013034363A patent/JP6003000B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013231023A (en) | 2013-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3278789A1 (en) | Cosmetic composition with multiple emulsion formulation having lamellar liquid crystal structure | |
EP1064909B1 (en) | High internal aqueous phase water-in-oil type emulsion cosmetic composition | |
JP2007314442A (en) | Oil-in-water type emulsified cosmetic | |
JP6339376B2 (en) | Cosmetics | |
CN106974848B (en) | Fischer-Tropsch wax liquid crystal cosmetic and preparation method thereof | |
KR101633639B1 (en) | Nano gel emulsion having similar structure with cell membrane using self-assembled gel characteristics and osmetic composition using the same | |
KR20180106106A (en) | Oil-in-water emulsion cosmetic composition improving deviation of emulsion particle size, and preparing method for the same | |
CN101827578A (en) | Inverted vesicle | |
JP6003000B2 (en) | Cosmetics and method for producing cosmetics | |
CN107735073B (en) | Cosmetic composition for making up comprising a layered structure | |
JP6531514B2 (en) | Emulsified composition | |
JP2001220311A (en) | Water-in-oil type high internal water phase emulsion cosmetic | |
JP6222642B2 (en) | Emulsifier, emulsion, method for producing emulsifier, and raw material for producing emulsifier | |
WO2013094683A1 (en) | Composition for skin containing silicone base | |
JP2000072618A (en) | Emulsifying agent for preparation for external use for skin | |
JP4150280B2 (en) | High internal water phase oil-in-water emulsified cosmetic | |
JP2002145733A (en) | Solid water-in-oil type emulsion cosmetic | |
JP2024506121A (en) | water-based emulsion | |
JP5306676B2 (en) | Sucrose fatty acid ester and emulsifier for oil-in-water emulsion composition | |
JP5295695B2 (en) | Thickening gelling agent | |
JP2020090454A (en) | High inner phase w/o emulsion composition and cosmetic using the same | |
KR101662331B1 (en) | Oil-in-water type cosmetic emulsion | |
BR112020002821B1 (en) | EMULSIFYING SYSTEM, PERSONAL CARE PRODUCT, METHOD AND USE | |
JP2019196318A (en) | High internal phase w/o type emulsified composition and cosmetic | |
JP3898657B2 (en) | W / O / W emulsion external composition for skin and production method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150519 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150519 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150615 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150820 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160301 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160425 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160809 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160818 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6003000 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |